MEDIPAL Group of Companies has become a strategic partner of Sanofi. As part of this agreement, from January 2022, MEDIPAL is responsible for the distribution and sale in the CIS countries of a line of well-established brands in the OTC segment (over-the-counter drugs) in therapeutic categories such as allergies, coughs, liver/digestive tract diseases, painkillers, vitamins, and supplements.
We are confident that we will be able to provide the required level of support, responsibility, and expertise to take the entrusted local brands to the next level.
Sanofi is one of the world leaders in healthcare, developing and implementing therapeutic solutions to meet the various needs of patients. The company’s vision rests on the following principles of growth: modern solutions to treat diabetes mellitus, human vaccines, innovative medicines, over-the-counter drugs, health products, emerging markets, and veterinary drug products.